Related Experiment Video
Updated: Feb 2, 2026
09:29
A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision
Published on: February 11, 2014
13.5K
A Novel Vision-Enhancing Technology for Low-Vision Impairments.
Carmelo Lodato1, Patrizia Ribino2
1Istituto di Calcolo e Reti ad Alte Prestazioni, via Ugo La Malfa 153, Palermo, Italy. carmelo.lodato@icar.cnr.it.
Journal of Medical Systems
|November 9, 2018
Summary
This study introduces a new vision aid technology to help individuals with vision loss from retinal diseases. The system uses 3D visualization and eye tracking to improve visual field perception and quality of life.
Area of Science:
- Ophthalmology
- Biomedical Engineering
- Computer Science
Background:
- Ocular disorders, particularly vitreoretinal pathologies and degenerative retinal diseases like macular degeneration, are prevalent, especially in older adults.
- These conditions lead to significant visual impairments, affecting central and peripheral vision and impacting millions worldwide.
- The rising incidence necessitates innovative solutions for managing and mitigating the effects of vision loss.
Purpose of the Study:
- To present a novel vision aid technology designed to correct or attenuate visual field defects.
- To enhance the quality of life for individuals suffering from vision impairments due to ocular pathologies or trauma.
- To explore the potential of this technology in supporting ocular dysfunction diagnosis and disease progression monitoring.
Main Methods:
- Integration of 3D visualization techniques for immersive visual perception.
- Implementation of precise eye-tracking systems to monitor gaze and visual attention.
- Application of advanced image processing algorithms to manipulate visual input and compensate for defects.
Main Results:
- The developed technology demonstrates the potential to correct or attenuate visual field deficits.
- It offers a significant improvement in the perceived visual experience for users with visual impairments.
- The system's adaptability suggests broad applicability across various ocular conditions.
Conclusions:
- The novel vision aid technology offers a promising solution for individuals with vision loss from retinal diseases.
- This innovation has the potential to significantly improve patient quality of life and aid in clinical diagnostics.
- The technology is protected by an International Application in Patent Cooperation Treaty (PCT).
Related Concept Videos
01:24Vision
60.0K
Vision is the result of light being detected and transduced into neural signals by the retina of the eye. This information is then further analyzed and interpreted by the brain. First, light enters the front of the eye and is focused by the cornea and lens onto the retina—a thin sheet of neural tissue lining the back of the eye. Because of refraction through the convex lens of the eye, images are projected onto the retina upside-down and reversed.
60.0K
01:24Color Vision
1.5K
Color perception begins in the retina, the light-sensitive layer at the back of the eye. Two main theories explain how colors are seen: the trichromatic theory and the opponent-process theory. The trichromatic theory, proposed by Thomas Young in 1802 and extended by Hermann von Helmholtz in 1852, suggests that color vision is based on three types of cone receptors in the retina. These cones are sensitive to different but overlapping ranges of wavelengths corresponding to red, blue, and green.
1.5K
01:15Depth Perception and Spatial Vision
2.0K
Depth perception is the ability to perceive objects three-dimensionally. It relies on two types of cues: binocular and monocular. Binocular cues depend on the combination of images from both eyes and how the eyes work together. Since the eyes are in slightly different positions, each eye captures a slightly different image. This disparity between images, known as binocular disparity, helps the brain interpret depth. When the brain compares these images, it determines the distance to an object.
2.0K
01:31Hybridoma Technology
17.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.7K
03:00Self-Evaluation: Self-Enhancement and Self-Verification
5.8K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
01:17Factors Affecting Renal Clearance: Renal Impairment
469
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
469